ERBIN and lung cancer: To examine ERBIN's effect on TGF‐β‐induced EMT, we analyzed breast [23] and lung cancer patient [24] cohorts and found that ERBIN positively correlates with the epithelial marker CDH1 (encoding E‐Cadherin) and negatively correlates with the mesenchymal markers CDH2 (encoding N‐Cadherin) and SNAI1 (Supplementary Fig. S1A,B).